Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-041612
Filing Date
2022-07-08
Accepted
2022-07-08 16:05:40
Documents
1
Period of Report
2022-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4011
  Complete submission text file 0001209191-22-041612.txt   5614
Mailing Address ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address
DOUGLAS RICHARD (Reporting) CIK: 0001021015 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40674 | Film No.: 221074426
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878
Business Address 22 FIRSTFIELD ROAD SUITE 250 GAITHERSBURG MD 20878 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research